Each episode of AJP Audio brings you an in-depth look at one of the articles featured in that month’s issue of The American Journal of Psychiatry, the official journal of the American Psychiatric Association. Wide-ranging interviews with article authors cover the background, rationale, main findings, and future implications of the research. This podcast is subject to the Terms of Use at ww.psychiatry.org. The views and opinions expressed in this podcast are those of the individual speakers only and do not necessarily represent the views of the American Psychiatric Association, its officers, trustees, or members. The content of this podcast is provided for general informational purposes only and is not intended as, and shall not be understood or construed as, medical or any other type of professional advice nor does it represent any statement of the standard of care. We strongly recommend that any listener follow the advice of physicians directly involved in their care and contact their local emergency response number for any medical emergency. The information within this podcast is provided as-is and is not guaranteed to be correct, complete, or accurate.
https://ajp.psychiatryonline.org/audio
Gesamtlänge aller Episoden: 3 days 20 hours 9 minutes
episode 64: May 2012 Highlights
May 2012 Highlights: premenstrual dysphoric disorder and DSM-5; borderline symptoms and suicidal behaviors; treating polydrug dependence with a naltrexone implant; neural network functional connectivity during and after an episode of delirium.
episode 63: April 2012 Highlights
April 2012 Highlights: postpartum obsessions and compulsions; anhedonia in schizophrenia; functional outcomes of psychosis; neural responses to stress and drug cues in men and women with cocaine dependence.
episode 62: March 2012 Highlights
March 2012 Highlights: striatal dopamine transporter abnormalities in ADHD; gastric bypass and antidepressant pharmacokinetics; fluoxetine for autism spectrum disorders; suicidal behavior and anticonvulsants; cerebral emboli and cognitive decline.
episode 61: February 2012 Highlights
February 2012 Highlights: abnormal thyroid function tests; PPHN and serotonin reuptake inhibitors; childhood maltreatment, course of depression, and treatment outcome; striatal response to negative and positive stimuli in depression; ADHD medications.
episode 60: January 2012 Highlights
January 2012 Highlights: Insurance parity in Oregon; adolescent behaviors and mental health outcomes, antipsychotic mortality risks; PTSD and World Trade Center attacks; religiosity and depression in offspring of depressed parents.
episode 59: December 2011 Highlights
December 2011 Highlights: introducing psychiatry to rural physicians in China; fear extinction disorders as a model for anxiety disorders; validity of a suicide severity rating scale; age at immigration and future risk of psychotic disorders.
November 2011 Highlights
November 2011 Highlights: clozapine re-challenge after eosinophilia; gray matter volume in ADHD; inattention and graduation; psychosis diagnostic stability; medical care management;;mood episodes in over 2,000 pregnancies and postpartum periods.
episode 58: October 2011 Highlights
October 2011 Highlights: alcohol consumption, stress, and circadian rhythm gene; T3 augmentation of antidepressants; lithium vs valproate for preventing suicidal behavior; antipsychotic use for anxiety; CBT for depression in Parkinson’s disease
episode 57: September 2011 Highlights
September 2011 Highlights: candidate genes and endophenotypes for schizophrenia; the metabolic effects of switching to aripiprazole; genetics in PTSD; depressive symptoms and inflammation in coronary heart disease; prevalence of autism spectrum disorder.
episode 56: August 2011 Highlights
August 2011 Highlights: complications of medical marijuana; depression and chromosome 3; cognition and antipsychotics; schizophrenia, Toxoplasma gondii, and HSV1; functioning in youth at high psychosis risk.